Search

Search Results

• 

  In vitro effect of anti-β2 glycoprotein I antibodies on P-selectin expression, a marker of platelet activation

  A. Bontadi, A. Ruffatti, S Giannini, E. Falcinelli, M. Tonello, A. Hoxha, P. Gresele, L. Punzi

  35-39

  19-03-2012

  Published: 19 March 2012

  1450

  PDF: 633
• 

  The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus

  M. Taraborelli, M.G. Lazzaroni, N. Martinazzi, M. Fredi, I. Cavazzana, F. Franceschini, A. Tincani

  137-143

  16-12-2016

  Published: 16 December 2016

  2147

  PDF: 1280
• 

  Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease

  S. Piantoni, L. Andreoli, F. Allegri, P.L. Meroni, A. Tincani

  307-313

  11-12-2012

  Published: 11 December 2012

  2190

  PDF: 1166
• 

  Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus

  L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria

  314-320

  11-12-2012

  Published: 11 December 2012

  2417

  PDF: 1207
• 

  The history of antiphospholipid syndrome

  A. Tincani, G. Fontana, C. Mackworth-Young

  21-03-2023

  Published: 21 March 2023

  2069

  PDF: 1637
• 

  Adrenal hemorrhage and non-ST elevation myocardial infarction: an antiphospholipid syndrome dilemma

  G. El Hasbani, M. Del Pilar Morel, B. Tandoh, J.F. Vargas, R. Crusio

  18-09-2023

  Published: 18 September 2023

  1061

  PDF: 481

• Primary antiphosholipid syndrome and hyperomocysteinemia: a study of a group of 29 patients

  T. Del Ross, A. Ruffatti, M. Tonello, G. Salmistraro, A. Calligaro, M. Favaro, M. Ciprian, S. Todesco

  283-287

  Published:

  901

  PDF: 1063

• Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for “non-criteria” antiphospholipid antibodies

  S. Mancuso, M. De Michele, S. Truglia, A. Capozzi, L. Rapino, I. Berto, C. Alessandri, D. Toni, V. Manganelli, M. Sorice, F. Conti

  25-09-2024

  Published: 25 September 2024

  720

  PDF: 136

• Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients

  S. Cuffaro, T. Del Ross, M. Tonello, A. Bontadi, S. Olivieri, E. Salvan, A. Ruffatti, L. Punzi

  51-59

  Published:

  1373

  PDF: 745

• Role of anti-prothrombin in antiphospholipid syndrome

  M. Cinquini, M. Vianelli, F. Allegri, R. Cattaneo, G. Balestrieri, A. Tincani

  243-250

  Published:

  794

  PDF: 1305

• Laboratory diagnosis of antiphospholipid syndrome

  V. Pengo, A. Ruffatti

  187-191

  Published:

  790

  PDF: 749
• 

  Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1

  C. Nalli, L. Andreoli, M. Motta, G.L. Norman, Z. Shums, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, A. Meini, V. Medeghini, T. Avcin, P.L. Meroni, A. Tincani

  91-96

  Published:

  1158

  PDF: 716
• 

  Biclonal gammopathy of undetermined significance in a patient with systemic lupus erythematosus and antiphospholipid syndrome

  V. Bruzzese, P. Scolieri, J. Pepe

  07-02-2022

  Published: 7 February 2022

  5657

  PDF: 602
• 

  Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis

  D.J. Manzella, L. Vicente, A.A. Pérez de la Hoz, R.J. Zamora, G. De Rosa, A.A. Pisarevsky

  92-98

  09-07-2019

  Published: 9 July 2019

  1312

  PDF: 972

• Sensibility and specificity for pregnancy morbidity of anti-b2-glycoprotein I antibodies in antiphospholipid syndrome

  M. Tonello, A. Ruffatti, M. Favaro, T. Del Ross, D. Zamboni, P. Grypiotis, A. Cavazzana, M. Ciprian, S. Todesco

  262-266

  Published:

  1083

  PDF: 1013

• Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?

  L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni

  185-191

  Published:

  1105

  PDF: 1058

• Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with reumatic diseases

  P. Grypiotis, A. Ruffatti, M. Tonello, C. Winzler, C. Radu, S. Zampieri, M. Favaro, A. Calligaro, S. Todesco

  232-237

  Published:

  1595

  PDF: 5891

• Multiple Sclerosis and autoimmune diseases: clinical cases and review of the literature

  G. Castellino, A. Protti, B. Canesi

  196-203

  Published:

  943

  PDF: 5181

• Clinical value of antibodies to lysobisphosphatidic acid in patients with primary antiphospholipid sindrome

  S. Olivieri, A. Ruffatti, A. Bontadi, A. Cavazzana, E. Salvan, S. Cuffaro, S. Giunco, L. Punzi

  107-112

  Published:

  1213

  PDF: 685

• Subpopulations of anti-β2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β2glycoprotein I

  L. Andreoli, C. Nalli, M. Motta, G.L. Norman, W.L. Binder, M. Nuzzo, M. Frassi, A. Lojacono, T. Avcin, P.L. Meroni, A. Tincani

  189-194

  Published:

  1035

  PDF: 598

• Diagnostic perspectives in the reumathological vasculitis: the role of the videocapillaroscopic analysis

  C. Pizzorni, A. Sulli, C. Craviotto, M. Tuccio, B. Seriolo, M. Cutolo

  99-104

  Published:

  1025

  PDF: 1523